Investor profile
Sanofi Ventures has backed 10 European tech companies across 11 funding rounds between 2020 and 2025, joining rounds totalling €792M. Most active in Healthtech and Transportation. Data as of 7 Aug 2026.
Also recorded as: Sanofi
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Owkin | France | 1 | €159M |
| Aqemia | France | 1 | €129M |
| SpliceBio | Spain | 1 | €118M |
| OMass Therapeutics | UK | 1 | €90M |
| Agomab Therapeutics | Belgium |
| 1 |
| €83M |
| MinervaX | Denmark | 2 | €76M |
| Lava Therapeutics | Netherlands | 1 | €70M |
| Gyroscope Therapeutics | UK | 1 | €35M |
| Eligo Bioscience | France | 1 | €28M |
| Livmed’s | France | 1 | €5.0M |
| €90M |
| 2022-04 |
| Agomab Therapeutics | Series D+ | €83M | 2024-10 |
| Lava Therapeutics | Series C | €70M | 2020-09 |
| MinervaX | Other | €54M | 2023-10 |
| Gyroscope Therapeutics | Other | €35M | 2021-11 |
| Eligo Bioscience | Series B | €28M | 2023-12 |
| MinervaX | Other | €22M | 2022-12 |
